Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells

Journal of Cellular and Molecular Medicine

Volumn 15, Issue 11, 2011, Pages 2343-2352

  Han, Zhipeng ^a   Tian, Zhiqiang ^a,b   Lv, Gang ^a   Zhang, Li ^a   Jiang, Guocheng ^a   Sun, Kai ^a   Wang, Chenyang ^a   Bu, Xinxin ^a   Li, Rong ^a   Shi, Yufang ^c   Wu, Mengchao ^a   Wei, Lixin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b 101th Hospital of Chinese People's Liberation Army   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Inducible nitric oxide synthase; Mesenchymal stem cells; Proinflammatory cytokines

Indexed keywords

GAMMA INTERFERON; INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; EXPERIMENTAL MELANOMA; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; MALE; MESENCHYMAL STEM CELL; METABOLISM; MOUSE; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE; TUMOR ESCAPE;

ANIMALS; BONE MARROW CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; IMMUNE TOLERANCE; IMMUNOSUPPRESSION; INTERFERON-GAMMA; MALE; MELANOMA, EXPERIMENTAL; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RNA INTERFERENCE; RNA, SMALL INTERFERING; TUMOR ESCAPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 80054938093     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2010.01215.x     Document Type: Article

References (23)

1. Pittenger MF, Mackay AM, Beck SC, et al Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-7.
2. Barry FP, Murphy JM. Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol. 2004; 36: 568-84.
3. da Silva Meirelles L, Chagastelles PC, et al Mesenchymal stem cells reside in virtually all post-natal organs and tissues. J Cell Sci. 2006; 119: 2204-13.
4. Noel D, Djouad F, Jorgense C. Regenerative medicine through mesenchymal stem cells for bone and cartilage repair. Curr Opin Investig Drugs. 2002; 3: 1000-4.
5. Sato K, Ozaki K, Oh I, et al Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood. 2007; 109: 228-34.
6. Rasmusson I, Ringden O, Sundberg B, et al Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res. 2005; 305: 33-41.
7. Krampera M, Glennie S, Dyson J, et al Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood. 2003; 101: 3722-9.
8. Di Nicola M, Carlo-Stella C, Magni M, et al Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood. 2002; 99: 3838-43.
9. Koc ON, Day J, Nieder M, et al Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH). Bone Marrow Transplant. 2002; 30: 215-22.
10. Djouad F, Fritz V, Apparailly F, et al Reversal of the immunosuppressive properties of mesenchymal stem cells by tumor necrosis factor alpha in collagen-induced arthritis. Arthritis Rheum. 2005; 52: 1595-603.
11. Zappia E, Casazza S, Pedemonte E, et al Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood. 2005; 106: 1755-61.
12. Meisel R, Zibert A, Laryea M, et al Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2, 3-dioxygenase-mediated tryptophan degradation. Blood. 2004; 103: 4619-21.
13. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105: 1815-22.
14. Xu Y, Flies AS, Flies DB, et al Selective targeting of the LIGHT-HVEM costimulatory system for the treatment of graft-versus-host disease. Blood. 2007; 109: 4097-104.
15. Nauta AJ, Westerhuis G, Kruisselbrink AB, et al Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting. Blood. 2006; 108: 2114-20.
16. Sudres M, Norol F, Trenado A, et al Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice. J Immunol. 2006; 176: 7761-7.
17. Ren G, Zhang L, Zhao X, et al Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008; 2: 141-50.
18. Djouad F, Plence P, Bony C, et al Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003; 102: 3837-44.
19. Khakoo AY, Pati S, Anderson SA, et al Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med. 2006; 203: 1235-47.
20. Nakamizo A, Marini F, Amano T, et al Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res. 2005; 65: 3307-18.
21. Niedbala W, Cai B, Liew FY. Role of nitric oxide in the regulation of T cell functions. Ann Rheum Dis. 2006; 65: iii37-40.
22. Xu W, Zhang X, Qian H, et al Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med. 2004; 229: 623-31.
23. Hall BM, Fortney JE, Taylor L, et al Stromal cells expressing elevated VCAM-1 enhance survival of B lineage tumor cells. Cancer Lett. 2004; 207: 229-39.